Nov 04, 2019 / 10:30AM GMT
Operator
Good day, ladies and gentlemen, and a very warm welcome to the Q2 FY '20 Earnings Conference Call of Advanced Enzyme Technologies Limited. From the management of Advanced Enzyme Technologies Limited, we have with us today Mr. Mukund Kabra, Whole Time Director; and Mr. Beni Prasad Rauka, Group CFO. (Operator Instructions) Please note that this conference is being recorded.
I'm now glad to hand the conference over to our Whole Time Director, Mr. Mukund Kabra. Thank you and over to you, sir.
Mukund Madhusudan Kabra - Advanced Enzyme Technologies Limited - Director of Operations & Whole Time Director
Good afternoon, everyone. I believe that the quarter 2 and first half results are in line with our expectations. We are progressing towards meeting our goal for financial year '20. Although the revenue growth is in single digit, the bottom line has shown a significant uptick as compared to last year. The substantial increase in profit is primarily because of additional gross contribution on increased sales and lower financial cost.
Evoxx is doing
Q2 2020 Advanced Enzyme Technologies Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot